Protecting the liver in children with acute lymphoblastic leukemia during chemotherapy
Tests diet changes and omega-3 supplements to protect the liver in children with leukemia.
Plain-language title generated from the registry record
Registry title: Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia
Key facts
- Where
- Cairo, EgyptSee the 2 sites
- Phase
- Phase 4
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teenagers newly diagnosed with acute lymphoblastic leukemia who are in the induction phase of chemotherapy at Ain Shams.
- Age
- 2 to 18 years
- Sex
- All sexes can join.
- Disease stage
- Newly diagnosed acute lymphoblastic leukemia, during the induction phase of chemotherapy.
Main reasons for not taking part
- Known chronic liver disease
Read by machine on 12 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 2 and 18 years old?
Source: NCT06918054, who can take part
Where in Egypt
- Ain Shams UniversityCairo, EgyptContact: Fatma SE Ebeid, MDTaking people
- Faculty of medicine Ain shams Research Institute-Clinical Research Center (MASRI-CRC)Cairo, EgyptContact: Fatma EbeidTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Ain Shams University
- Trial code
- NCT06918054
- Record updated
- 9 April 2025
- Original description
This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.Read full original descriptionShow less
Hepatoprotective Measures for Children and Adolescents With Acute Lymphoblastic Leukemia During Induction Chemotherapy
This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.
Inclusion: Children and adolescents aged from 2 to 18 years newly diagnosed with acute lymphoblastic leukemia during induction phase of chemotherapy treated at Ain Shams.
Exclusion: Known chronic liver disease.